Want to see HK:3689 full AI Analyst Report?
Top Page
Guangdong Kanghua Healthcare Co., Ltd. Class H
(3689)
Select Model
Select Model
Rating:71Outperform
Price Target:
HK$2.00
▲(5.26% Upside)
Action:Upgraded
Date:10/09/26
The score is driven primarily by improving but still uneven financial performance (rebounding profitability and manageable leverage, offset by volatile revenue and cash-flow trends), supported by a very attractive valuation (low P/E and high dividend yield). Technicals are moderately positive with price above key moving averages, though MACD remains slightly negative.
Positive Factors
Profitability rebound
The sharp improvement in net and operating margins indicates that the hospital platform regained meaningful earnings capacity in 2025. If sustained, stronger profitability can support reinvestment in clinical services, improve resilience, and provide a more durable base for future cash generation.
Negative Factors
Revenue contraction
The 2025 revenue decline and uneven historical growth indicate that demand or service volumes have not followed a stable upward path. Continued top-line volatility could limit operating leverage, make margin improvement harder to sustain, and reduce visibility into the pace of durable business expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability rebound
The sharp improvement in net and operating margins indicates that the hospital platform regained meaningful earnings capacity in 2025. If sustained, stronger profitability can support reinvestment in clinical services, improve resilience, and provide a more durable base for future cash generation.
Read all positive factors
Guangdong Kanghua Healthcare Co., Ltd. Class H (3689) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$581.85M
Dividend Yield10.92%
Average Volume (3M)1.31K
Price to Earnings (P/E)5.3
Beta (1Y)0.21
Revenue Growth-0.27%
EPS Growth29.73%
CountryHK
Employees3,728
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.28
Shares Outstanding84,394,000
10 Day Avg. Volume200
30 Day Avg. Volume1,313
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.34
Price to Sales (P/S)0.26
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guangdong Kanghua Healthcare Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Service...
How the Company Makes Money
The company primarily makes money by providing medical services to patients through its hospitals and related healthcare facilities. Its core revenue stream typically consists of fees charged for clinical services (e.g., outpatient visits, inpatie...
Guangdong Kanghua Healthcare Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
73
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.96B | 1.97B | 2.06B | 2.04B | 1.85B | 1.95B |
| Gross Profit | 365.16M | 359.37M | 321.87M | 364.37M | 261.35M | 352.75M |
| EBITDA | 297.82M | 253.39M | 224.86M | 305.92M | 233.79M | 298.46M |
| Net Income | 95.32M | 97.01M | 15.34M | 121.06M | 59.70M | 94.31M |
Balance Sheet | ||||||
| Total Assets | 2.85B | 2.68B | 2.74B | 2.62B | 2.72B | 2.70B |
| Cash, Cash Equivalents and Short-Term Investments | 697.27M | 743.33M | 678.40M | 718.52M | 754.34M | 770.34M |
| Total Debt | 463.24M | 326.21M | 320.66M | 426.58M | 429.92M | 494.54M |
| Total Liabilities | 1.34B | 1.15B | 1.28B | 1.13B | 1.22B | 1.23B |
| Stockholders Equity | 1.49B | 1.51B | 1.44B | 1.42B | 1.49B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 223.04M | 234.48M | 193.15M | 73.31M | 106.20M | 162.19M |
| Operating Cash Flow | 278.09M | 282.66M | 280.13M | 204.19M | 221.40M | 333.37M |
| Investing Cash Flow | -180.65M | -238.75M | -87.33M | -107.72M | -83.16M | -299.33M |
| Financing Cash Flow | -211.56M | -46.31M | -251.71M | -55.56M | -110.88M | 23.27M |
Guangdong Kanghua Healthcare Co., Ltd. Class H Technical Analysis
Negative
1.90
Price Trends
1.83
Negative
1.79
Negative
1.75
Negative
Market Momentum
-0.02
Positive
40.19
Neutral
25.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3689, the sentiment is Negative. The current price of 1.9 is above the 20-day moving average (MA) of 1.80, above the 50-day MA of 1.83, and above the 200-day MA of 1.75, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 25.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3689.
Guangdong Kanghua Healthcare Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.66B | 8.34 | 6.97% | 10.27% | 3.85% | -1.23% | |
71 Outperform | HK$581.85M | 5.27 | 6.35% | 10.92% | -0.27% | 29.73% | |
67 Neutral | HK$1.05B | 10.10 | 5.57% | 2.29% | 4.75% | ― | |
66 Neutral | HK$703.50M | 285.71 | 0.20% | 2.00% | 20.54% | -96.74% | |
52 Neutral | HK$1.10B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$1.03B | 31.06 | 1.27% | ― | ― | ― |
* Healthcare Sector Average
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.74
-0.03
-1.97%
HK:1846
EuroEyes International Eye Clinic Limited
2.20
-1.09
-33.17%
HK:2219
Chaoju Eye Care Holdings Ltd.
2.36
<0.01
0.43%
HK:3309
C-MER Eye Care Holdings Limited
0.85
-0.91
-51.81%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.11
-40.07%
HK:6639
Arrail Group Ltd.
1.83
-0.09
-4.74%
Guangdong Kanghua Healthcare Co., Ltd. Class H Corporate Events
Guangdong Kanghua Healthcare Delivers Higher Profit on Lower Revenue in Interim Results
Aug 31, 2026
Guangdong Kanghua Healthcare Group reported interim revenue of RMB937.6 million for the six months ended 30 June 2026, a 4.5% decline from a year earlier as cost controls kept gross profit broadly flat. Profit for the period rose 10.5% to RMB36.0 ...
Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend
Aug 19, 2026
Guangdong Kanghua Healthcare Group has scheduled a board meeting for 31 August 2026 to review and approve the interim results for the six months ended 30 June 2026 and to decide on their release to the market. The board will also consider the paym...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.